secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edesa Biotech, Inc. (EDSA)
CIK:        0001540159
Form:       8-K
Filed at:   2022-05-20T23:59:59+00:00
Accession:  0001654954-22-007262
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Edesa Biotech holds 2022 annual meeting; all director nominees elected, say-on-pay approved
--------------------------------------------------------------------------------

- Annual meeting held May 18, 2022; 6,975,601 shares (50.1%) represented.
- All seven director nominees elected: Chao, Johnson, MacDonald, Nijhawan, Oakes, Pay, Sistilli.
- Advisory vote on executive compensation approved: 4,105,670 for, 373,029 against.
- Frequency vote chose 'every year' (4,213,160 votes); company will hold annual say-on-pay.
- MNP LLP appointed as independent auditor for 2023  with 6,860,304 votes in favor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1540159/000165495422007262/0001654954-22-007262-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1540159/000165495422007262/edsa_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-22-007262

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer